Drug class
Intravenous general anaesthetic; 2,6-disubstituted alkylphenol GABAA receptor modulator
Mechanism of action
Modulates GABAA receptor-mediated inhibitory neurotransmission, increasing neuronal inhibition and producing dose-dependent sedation and hypnosis. It is a structural analogue of propofol.
General use cases
- Induction of general anaesthesia in adults undergoing surgery, under the US FDA-approved Cypsedo product label (approved 29 May 2026).
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
